BrainCool AB (publ)
F:5YL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BrainCool AB (publ)
Capital Expenditures
BrainCool AB (publ)
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BrainCool AB (publ)
F:5YL
|
Capital Expenditures
-kr6.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Capital Expenditures
-kr1.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Capital Expenditures
-kr86.3m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-25%
|
|
|
Getinge AB
STO:GETI B
|
Capital Expenditures
-kr1.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Capital Expenditures
-kr20.6m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-35%
|
|
BrainCool AB (publ)
Glance View
BrainCool AB engages in the development, marketing, and trade of medical cooling systems for the healthcare sector. The company is headquartered in Lund, Skane. The company went IPO on 2014-05-07. The company develops a medical device for therapeutic brain cooling. BrainCool publ AB uses a patented cooling method developed by Dignitana AB, the marker of the DigniCap System for the prevention of chemotherapy-related hair loss. The technology used in the BrainCool System allows cooling of the neck, which helps to speed perfusion and cooling of blood before it reaches the brain. The therapeutic hypothermia device is dedicated to patients suffering from stroke, cardiac arrest, traumatic brain injury or neonatal asphyxia. BrainCool publ AB is a wholly owned subsidiary of Dignitana AB.
See Also
What is BrainCool AB (publ)'s Capital Expenditures?
Capital Expenditures
-6.5m
SEK
Based on the financial report for Dec 31, 2025, BrainCool AB (publ)'s Capital Expenditures amounts to -6.5m SEK.
What is BrainCool AB (publ)'s Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
4%
Over the last year, the Capital Expenditures growth was 14%. The average annual Capital Expenditures growth rates for BrainCool AB (publ) have been 4% over the past three years .
